Tag: CIED
Expert consensus statement establishes blueprint for holistic CIED lead management and...
A new expert consensus statement published recently in the journal Heart Rhythm details the latest recommendations aimed at guiding clinicians and patients in choosing...
Patients receiving CIEDs “at higher risk” for persistent opioid use
Persistent opioid use following a cardiac implantable electronic device (CIED) procedure is common, according to a study published in Circulation, which reports that 12%...
PADIT score predicts CIED infection risk
Five independent predictors of cardiac implantable electronic device (CIED) infection have been identified which could be used to aid physicians and patients in decision-making...
Cardiac device complications vary widely among hospitals
A study of 174 hospitals in Australia and New Zealand, published recently in the Annals of Internal Medicine, shows that the quality of care...
New bio envelope designed for S-ICDs launches in USA
Aziyo Biologics has announced the launch of their CanGaroo bio envelope specifically for use with subcutaneous implantable cardioverter-defibrillators (S-ICDs). It is the only cardiac implantable...
Low risk of repeat infection in reimplanted cardiac devices
It is safe to reimplant a new cardiac device after the removal of an infected one, and repeat infection rates are low, a large...